Your browser doesn't support javascript.
loading
PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction In Vitro and In Vivo.
Fröhlich, Lisa Marie; Niessner, Heike; Sauer, Birgit; Kämereit, Sofie; Chatziioannou, Eftychia; Riel, Simon; Sinnberg, Tobias; Schittek, Birgit.
Afiliación
  • Fröhlich LM; Division of Dermatooncology, Department of Dermatology, University of Tübingen, Tübingen, Germany.
  • Niessner H; Division of Dermatooncology, Department of Dermatology, University of Tübingen, Tübingen, Germany.
  • Sauer B; Division of Dermatooncology, Department of Dermatology, University of Tübingen, Tübingen, Germany.
  • Kämereit S; Division of Dermatooncology, Department of Dermatology, University of Tübingen, Tübingen, Germany.
  • Chatziioannou E; Division of Dermatooncology, Department of Dermatology, University of Tübingen, Tübingen, Germany.
  • Riel S; Department of Dermatology, University of Tübingen, Tübingen, Germany.
  • Sinnberg T; Division of Dermatooncology, Department of Dermatology, University of Tübingen, Tübingen, Germany.
  • Schittek B; Department of Dermatology, Venereology and Allergology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Cancer Res Commun ; 3(9): 1743-1755, 2023 09.
Article en En | MEDLINE | ID: mdl-37674529
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ataxia Telangiectasia / Melanoma Límite: Humans Idioma: En Revista: Cancer Res Commun Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ataxia Telangiectasia / Melanoma Límite: Humans Idioma: En Revista: Cancer Res Commun Año: 2023 Tipo del documento: Article País de afiliación: Alemania